Aurobindo Pharma announces 9th acquisition, receives US FTC approval to acquire Lannett Company for $250 million

Hyderabad: Aurobindo Pharma has announced that it has received approval from the US Federal Trade Commission (FTC) to acquire the Lannett Company. The cash-free, debt-free transaction is valued at $250 million and is expected to close by the end of June 2026.

This Pennsylvania-based generic pharmaceutical company specialises in developing and commercializing a diversified portfolio of complex, non opioid controlled substances, strengthening Aurobindo USA’s offerings in the segment. 

The Lannett Company has a manufacturing site in Seymour, Indiana, with a capacity to scale production to up to 4 billion doses annually, boosting Hyderabad-based Aurobindo’s supply chain resilience and increasing domestic pharmaceutical production. 

“This acquisition represents a highly compelling strategic and financial opportunity for Aurobindo USA. It accelerates our revenue growth, strengthens our U.S.-based manufacturing capabilities, and enhances our position in complex, non-opioid controlled substances. We are confident it will deliver immediate earnings accretion while creating long-term value for our shareholders through operational synergies and pipeline expansion. We are pleased to welcome the Lannett team and look forward to leveraging our combined strengths to expand and ensure reliable access to critical medications for patients.” Swami S. Iyer, Chief Executive Officer of Aurobindo Pharma USA, said in a press release. 

“We are delighted to be joining forces with Aurobindo. As one of the nation’s oldest generic pharmaceutical companies, Lannett has a proud history of helping patients access affordable medicines. Aurobindo’s market reach and resources will help make our portfolio of medicines even more affordable and accessible for patients everywhere. Our board and owners extend their sincere appreciation to the outstanding teams at both companies whose professionalism, commitment, and hard work have successfully brought us to this important moment. We look forward to building on all that has come before as we begin a bright and exciting next chapter.” Tim Crew, Lannett Company’s Chief Executive Officer, added.